SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Ajanta Pharma informs about board meeting

27 Apr 2023 Evaluate

Pursuant to Regulation 29 of the Listing Regulations, Ajanta Pharma has informed that a Meeting of the Board of Directors of the Company will be held on Friday, 5th May 2023 to consider and approve: Audited Financial Results (consolidated & standalone) of the Company for the quarter and year ended 31st March 2023 and Audited Financial Statements (consolidated & standalone) for the year ended 31st March 2023.

The above information is a part of company’s filings submitted to BSE.


Ajanta Pharma Share Price

3346.80 -75.90 (-2.22%)
01-Jul-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1865.95
Dr. Reddys Labs. 1339.35
Cipla 1456.95
Zydus Lifesciences 1108.85
Lupin 2396.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: